400, *CISPPACL, LUNG-NSCLC OR GYNECOLOGICAL-OVARIAN OR CERVICAL - PACLITAXEL, CISPLATIN. 401, *CISPPACL(IP), GYNECOLOGICAL - ...
46, 80122, Large cell carcinoma, NOS in situ, noninfiltrating, noninvasive. 47, 80123 ..... 480, 82439, Goblet cell carcinoid, unknown if primary or metastatic.
478, C253, Pancreatic duct, /1, D377, Neoplasm of uncertain or unknown ... C254 , Islets of Langerhans, /3, C254, Malignant neoplasm of endocrine pancreas.
635, C384, Pleura, NOS, 9050/0, D190, Benign neoplasm of mesothelial tissue of pleura. 636, C384, Pleura, NOS, 9050/3, C450, Mesothelioma of pleura.
455, C241, Ampulla of Vater, /3, C241, Malignant neoplasm ampulla of Vater ... 466, C250, Head of pancreas, /1, D377, Neoplasm of uncertain or unknown ...
412, *GEM-CARBO, GENITOURINARY - BLADDER OR LUNG-NSCLC OR GYNECOLOGY OR HEAD AND NECK OR BREAST, GEMCITABINE- CARBOPLATIN.
234, 1EX59LAXXA, Destruction, frontal sinus using autograft [e.g. fat, muscle] ... Destruction, oral and buccal mucosa using external approach and cryoprobe ...... Destruction, skin of face using ruby laser [e.g. for tattoo removal], Resection.
Cancer Care Ontario (CCO) and you. Patient Pathway. Is It Lung Cancer? A Patient Pathway is a way for you to learn about your journey and what to expect.
This Ontario Cancer Plan IV provides a comprehensive road map for the way Cancer Care Ontario, healthcare professionals and organizations, cancer.